Susquehanna International Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-142,500
| Closed | -$869K | – | 14452 |
|
|
2021
Q3 | $869K | Buy |
142,500
+30,400
| +27% | +$189K | ﹤0.01% | 7936 |
|
|
2021
Q2 | $923K | Buy |
112,100
+20,400
| +22% | +$173K | ﹤0.01% | 7991 |
|
|
2021
Q1 | $821K | Sell |
91,700
-200
| -0.2% | -$2.29K | ﹤0.01% | 8245 |
|
|
2020
Q4 | $1.06M | Buy |
91,900
+11,600
| +14% | +$135K | ﹤0.01% | 6588 |
|
|
2020
Q3 | $836K | Buy |
80,300
+13,200
| +20% | +$162K | ﹤0.01% | 6558 |
|
|
2020
Q2 | $882K | Buy |
67,100
+16,800
| +33% | +$174K | ﹤0.01% | 6201 |
|
|
2020
Q1 | $396K | Sell |
50,300
-43,300
| -46% | -$652K | ﹤0.01% | 7426 |
|
|
2019
Q4 | $1.94M | Buy |
93,600
+11,100
| +13% | +$187K | ﹤0.01% | 4377 |
|
|
2019
Q3 | $1.13M | Buy |
82,500
+3,300
| +4% | +$39.2K | ﹤0.01% | 5436 |
|
|
2019
Q2 | $974K | Sell |
79,200
-17,300
| -18% | -$200K | ﹤0.01% | 5723 |
|
|
2019
Q1 | $1.2M | Buy |
96,500
+80,300
| +496% | +$1.07M | ﹤0.01% | 4658 |
|
|
2018
Q4 | $183K | Sell |
16,200
-3,200
| -16% | -$50.2K | ﹤0.01% | 7823 |
|
|
2018
Q3 | $363K | Sell |
19,400
-3,500
| -15% | -$80.4K | ﹤0.01% | 7102 |
|
|
2018
Q2 | $592K | Sell |
22,900
-118,800
| -84% | -$3.08M | ﹤0.01% | 6451 |
|
|
2018
Q1 | $3.17M | Sell |
141,700
-139,400
| -50% | -$3.4M | ﹤0.01% | 3172 |
|
|
2017
Q4 | $7.04M | Sell |
281,100
-42,400
| -13% | -$1.04M | ﹤0.01% | 2158 |
|
|
2017
Q3 | $7.82M | Buy |
323,500
+140,900
| +77% | +$3.31M | ﹤0.01% | 2006 |
|
|
2017
Q2 | $3.69M | Buy |
182,600
+93,600
| +105% | +$1.95M | ﹤0.01% | 2816 |
|
|
2017
Q1 | $2.4M | Buy |
89,000
+39,200
| +79% | +$800K | ﹤0.01% | 3397 |
|
|
2016
Q4 | $947K | Sell |
49,800
-23,000
| -32% | -$440K | ﹤0.01% | 5648 |
|
|
2016
Q3 | $1.42M | Buy |
72,800
+5,100
| +8% | +$86.3K | ﹤0.01% | 4149 |
|
|
2016
Q2 | $1.01M | Buy |
+67,700
| New | +$851K | ﹤0.01% | 4862 |
|
|
2016
Q1 | – | Sell |
-36,600
| Closed | -$705K | – | 9912 |
|
|
2015
Q4 | $705K | Buy |
+36,600
| New | +$635K | ﹤0.01% | 6126 |
|
Susquehanna International Group's FLXN Position: Q4 2021 in Review
Susquehanna International Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 140,764 shares — an estimated $859K sold.
Susquehanna International Group first reported a position in FLXN in Q4 2016 and held it in 13 quarters. The position peaked at $2.51M in Q4 2017. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Susquehanna International Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Susquehanna International Group sold 140,764 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $859K.
- Susquehanna International Group first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 13 quarters.
- Susquehanna International Group's Flexion Therapeutics, Inc. position peaked at $2.51M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.